Immucor appoints new CEO as De Chirico retires
This article was originally published in Clinica
Executive Summary
Gioacchino De Chirico is retiring from his role as president and CEO of blood screening firm Immucor after 18 years with the company. He will be immediately replaced by Joshua Levine, who was most recently president and CEO of aesthetic medical device developer Mentor; Mentor was acquired by Johnson & Johnson in 2009 (www.clinica.co.uk, 19 January 2009). Mr Levine has also worked for Kinetic Concepts, American Hospital Supply Corporation, and Baxter International. During his tenure, Dr De Chirico guided Norcross, Georgia-based Immucor through several scandals: in 2009, the FDA threatened to revoke its biologics licence over concerns about its manufacturing processes (www.clinica.co.uk, 30 June 2009); the company was also investigated for potential anti-competitive practices (www.clinica.co.uk, 28 April 2009).